查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1750634

卵巢治疗市场规模、份额、趋势分析报告：按药物类别、程序、分销管道、地区和细分市场进行预测（2025-2030 年）

Polycystic Ovarian Syndrome Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Surgery, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

卵巢症候群治疗市场的成长和趋势：

根据 Grand View Research, Inc. 的新报告，全球卵巢治疗市场预计到 2030 年将达到 69.9 亿美元，2025 年至 2030 年的复合年增长率为 6.6%。

根据美国疾病管制与预防中心 (CDC) 的数据，卵巢症候群 (PCOS) 是女性不孕症最常见的原因。美国育龄女性中约有 6% 至 12% 患有 PCOS。此外，随着病情发展，会出现代谢异常，而延误治疗则可能导致第 2 型糖尿病。 PCOS 的严重程度会增加患者罹患子宫癌和子宫内膜癌的风险。因此，早期诊断和有效治疗对于患者的康復至关重要。

目前，市面上尚无针对该疾病的特效疗法。因此，治疗的主要目的是治疗方法。由于此综合征的症状各异，因此需要使用不同类别/组合的药物进行治疗。因此，市场领导者正致力于开发针对该疾病根源的特定药物/治疗方法。Astra Zeneca是参与开发此类药物的领导企业之一。

卵巢治疗市场报告重点

  • 根据药物类别，胰岛素增敏剂将占据市场主导地位，到 2024 年将占 36.0% 的份额。
  • 以手术方式计算，卵巢楔形切除术预计在预测期内将以显着的复合年增长率成长。
  • 根据销售管道，预计线上供应商部门在预测期内将实现最快的复合年增长率。
  • 预计亚太卵巢治疗市场在预测期内将实现最快的复合年增长率。

目录

第一章调查方法与范围

第二章执行摘要

3.卵巢治疗市场变数、趋势和范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 卵巢治疗市场分析工具
    • 波特的分析
    • PESTEL分析

第四章卵巢治疗市场：药物类别估计与趋势分析

  • 细分仪表板
  • 卵巢治疗市场：2024 年和 2030 年药物类别变化分析
  • 口服避孕药
  • 抗雄激素
  • 胰岛素增敏剂
  • 抗忧郁症
  • 肥胖预防

第五章卵巢治疗市场：手术估计与趋势分析

  • 细分仪表板
  • 卵巢治疗市场：2024 年和 2030 年手术变异分析
  • 卵巢楔形切除术
  • 腹腔镜卵巢打孔术

第六章卵巢治疗市场：通路评估与趋势分析

  • 细分仪表板
  • 卵巢治疗市场：2024 年和 2030 年分销管道变化分析
  • 院内药房
  • 药局和零售药局
  • 线上提供者

第七章卵巢治疗市场：区域估计与趋势分析

  • 2024 年及 2030 年多卵巢症候群治疗市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • AstraZeneca
    • Bayer AG
    • Merck KGaA.
    • Abbott
    • Pfizer, Inc
    • Sanofi
    • Bristol Myers Squibb Company
    • Teva Pharmaceutical Industries Ltd
    • Novartis AG
    • Ferring BV
Product Code: GVR-2-68038-203-7

Polycystic Ovarian Syndrome Treatment Market Growth & Trends:

The global polycystic ovarian syndrome treatment market size is estimated to reach USD 6.99 billion by 2030, registering a CAGR of 6.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. According to the Centers of Disease Control & Prevention (CDC), Polycystic Ovary Syndrome (PCOS) is the most common cause of female infertility. Approximately 6% to 12% women of reproductive age suffer from PCOS in the U. S. Moreover, progression of this condition can lead to metabolic abnormalities, which may result in development of type 2 diabetes, if the syndrome is not treated on time. The severity of the disorder increases the risk of developing uterine and endometrial cancers in patients. Thus, early diagnosis and effective treatment are significant for successful recovery.

Presently, no specific drug is commercially available for this condition. Thus, treating symptoms is the prime aim of the treatment regimen. Owing to the various symptoms associated with this syndrome, a range of drug class/combinations is used in the treatment. Therefore, market leaders are focusing on developing a specific drug/treatment to cure the root cause of this disease. AstraZeneca is one of the leaders involved in developing such a drug.

Polycystic Ovarian Syndrome Treatment Market Report Highlights:

  • Based on drug class, the insulin-sensitizing agents dominated the market and accounted for a share of 36.0% in 2024.
  • By surgery, the ovarian wedge resection segment is expected to grow at a significant CAGR over the forecast period.
  • Based on the distribution channel, the online providers segment is expected to register the fastest CAGR during the forecast period.
  • Asia Pacific's polycystic ovarian syndrome treatment market is estimated to register the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Polycystic Ovarian Syndrome Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Polycystic Ovarian Syndrome Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Polycystic Ovarian Syndrome Treatment Market: Drug Class Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Polycystic Ovarian Syndrome Treatment Market:, Drug Class Movement Analysis, 2024 & 2030 (USD Billion)
  • 4.3. Oral Contraceptives
    • 4.3.1. Oral Contraceptives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Antiandrogens
    • 4.4.1. Antiandrogens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Insulin-sensitizing Agent
    • 4.5.1. Insulin-sensitizing Agent Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Antidepressant
    • 4.6.1. Antidepressant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.7. Anti-obesity
    • 4.7.1. Anti-obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Polycystic Ovarian Syndrome Treatment Market: Surgery Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Polycystic Ovarian Syndrome Treatment Market: Surgery Movement Analysis, 2024 & 2030 (USD Billion)
  • 5.3. Ovarian Wedge Resection
    • 5.3.1. Ovarian Wedge Resection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Laparoscopic Ovarian Drilling
    • 5.4.1. Laparoscopic Ovarian Drilling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Polycystic Ovarian Syndrome Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Polycystic Ovarian Syndrome Treatment Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Billion)
  • 6.3. Hospital Pharmacy
    • 6.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Drug Store & Retail Pharmacy
    • 6.4.1. Drug Store & Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Online Providers
    • 6.5.1. Online Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Polycystic Ovarian Syndrome Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Polycystic Ovarian Syndrome Treatment Market Share, By Region, 2024 & 2030 (USD Billion)
  • 7.2. North America
    • 7.2.1. North America Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.2. U.S.
    • 7.2.3. U.S. Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.4. Canada
      • 7.2.4.1. Canada Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.5. Mexico
      • 7.2.5.1. Mexico Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.3. Europe
    • 7.3.1. Europe Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.2. UK
      • 7.3.2.1. UK Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.4. France
      • 7.3.4.1. France Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2. China
      • 7.4.2.1. China Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4. India
      • 7.4.4.1. India Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. AstraZeneca
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Bayer AG
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Merck KGaA.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Abbott
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Pfizer, Inc
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Sanofi
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Bristol Myers Squibb Company
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Teva Pharmaceutical Industries Ltd
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Novartis AG
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Ferring B.V.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Leading Market Players Anticipated to Witness Highest Growth
  • Table 4. Global polycystic ovarian syndrome treatment market, By Region, 2018 - 2030 (USD Billion)
  • Table 5. Global polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 6. Global polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 7. Global polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 8. North America polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 9. North America polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 10. North America polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 11. North America polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 12. U.S. polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 13. U.S. polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 14. U.S. polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 15. Canada polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 16. Canada polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 17. Canada polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 18. Mexico polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 19. Mexico polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 20. Mexico polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 21. Europe polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 22. Europe polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 23. Europe polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 24. Europe polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 25. UK polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 26. UK polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 27. UK polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28. Germany polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 29. Germany polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 30. Germany polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 31. France polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 32. France polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 33. France polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 34. Italy polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 35. Italy polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 36. Italy polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 37. Spain polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 38. Spain polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 39. Spain polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40. Denmark polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 41. Denmark polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 42. Denmark polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 43. Sweden polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 44. Sweden polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 45. Sweden polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 46. Norway polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 47. Norway polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 48. Norway polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 49. Asia Pacific polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 50. Asia Pacific polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 51. Asia Pacific polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52. Asia Pacific polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 53. Japan polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 54. Japan polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 55. Japan polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 56. China polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 57. China polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 58. China polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 59. India polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 60. India polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 61. India polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 62. South Korea polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 63. South Korea polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 64. South Korea polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 65. Australia polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 66. Australia polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 67. Australia polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 68. Thailand polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 69. Thailand polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 70. Thailand polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 71. Latin America polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 72. Latin America polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 73. Latin America polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 74. Latin America polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 75. Brazil polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 76. Brazil polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 77. Brazil polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 78. Argentina polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 79. Argentina polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 80. Argentina polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 81. Middle East and Africa polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 82. Middle East and Africa polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 83. Middle East and Africa polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 84. Middle East & Africa polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 85. South Africa polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 86. South Africa polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 87. South Africa polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 88. Saudi Arabia polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 89. Saudi Arabia polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 90. Saudi Arabia polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 91. UAE polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 92. UAE polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 93. UAE polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 94. Kuwait polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 95. Kuwait polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 96. Kuwait polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Polycystic ovarian syndrome treatment market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Polycystic ovarian syndrome treatment market:, By Drug Class movement analysis
  • Fig. 17 Polycystic ovarian syndrome treatment market:, By Drug Class segment dashboard
  • Fig. 18 Polycystic ovarian syndrome treatment market, By Drug Class outlook: Key takeaways
  • Fig. 19 Luminometric Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Enzymatic Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Bioluminescence Resonance Energy Transfer (BRET) Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Cell-based Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Anti-obesity Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Polycystic ovarian syndrome treatment market: Surgery movement analysis
  • Fig. 25 Polycystic ovarian syndrome treatment market Surgery outlook: Key takeaways
  • Fig. 26 Ovarian Wedge Resection Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Laparoscopic Ovarian Drilling Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Food Safety and Quality TestingPolycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Other Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Polycystic ovarian syndrome treatment market: Distribution Channel movement analysis
  • Fig. 32 Polycystic ovarian syndrome treatment market Distribution Channel outlook: Key takeaways
  • Fig. 33 Hospital Pharmacy Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Drug Store & Retail Pharmacy Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Online Providers Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Regional outlook, 2024 & 2030
  • Fig. 37 Regional market dashboard
  • Fig. 38 Regional market place: Key takeaways
  • Fig. 39 North America polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 42 Mexico polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 43 Europe polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 44 UK polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 45 Germany polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 46 Spain polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 47 France polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 48 Italy implantable Market, 2018 - 2030 (USD Billion)
  • Fig. 49 Denmark polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 50 Sweden polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 51 Norway polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 52 Asia Pacific polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 53 Japan polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 54 China polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 55 India polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 56 South Korea polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 57 Australia polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 58 Thailand polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 59 Latin America polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 60 Brazil polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 62 MEA polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 63 South Africa polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 64 Saudi Arabia polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 67 Heat map analysis
  • Fig. 68 Market differentiators